1. Home
  2. SLG vs BHC Comparison

SLG vs BHC Comparison

Compare SLG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Green Realty Corp

SLG

SL Green Realty Corp

N/A

Current Price

$49.15

Market Cap

3.5B

Sector

Real Estate

ML Signal

N/A

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

N/A

Current Price

$8.35

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLG
BHC
Founded
1980
N/A
Country
United States
Canada
Employees
1289
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
SLG
BHC
Price
$49.15
$8.35
Analyst Decision
Hold
Hold
Analyst Count
17
7
Target Price
★ $55.65
$8.40
AVG Volume (30 Days)
1.0M
★ 3.9M
Earning Date
10-21-2026
10-28-2026
Dividend Yield
★ 5.07%
N/A
EPS Growth
N/A
★ 423.08
EPS
★ N/A
N/A
Revenue
$1,003,046,000.00
★ $8,724,000,000.00
Revenue This Year
N/A
$7.43
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 13.18
N/A
52 Week Low
$34.77
$4.33
52 Week High
$60.09
$9.04

Technical Indicators

Market Signals
Indicator
SLG
BHC
Relative Strength Index (RSI) 46.63 65.87
Support Level $48.65 $7.86
Resistance Level $49.71 N/A
Average True Range (ATR) 1.83 0.43
MACD -0.08 0.03
Stochastic Oscillator 11.98 74.42

Price Performance

Historical Comparison
SLG
BHC

About SLG SL Green Realty Corp

SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 30.6 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Share on Social Networks: